Cathay Biotech Inc. (SHA:688065)
39.03
-0.18 (-0.46%)
Nov 6, 2026, 3:00 PM CST
Cathay Biotech Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Cathay Biotech stock has a consensus rating of "Strong Buy" and an average price target of ¥55.09. The average 1-year stock price forecast is 41.15% higher than the current stock price, while the lowest is ¥50.00 (+28.11%) and the highest is ¥60.18 (+54.19%).
Price Target: ¥55.09 (+41.15%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Cathay Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 1 | 1 | 2 |
Financial Forecast
Revenue This Year
3.71B
from 3.30B
Increased by 12.62%
Revenue Next Year
4.29B
from 3.71B
Increased by 15.49%
EPS This Year
n/a
EPS Next Year
n/a
Financial currency is CNY.